Table 4.
Profile of multidrug resistant enterococci isolates at the UoGTH, February 28, 2014 to May 1, 2014
| Resistance rate | Combination of antibiotics | No. (%) of isolates tested |
|---|---|---|
| R5 | TE, E, DOXY, CIP, CAF | 1 |
| R5 | TE, E, DOXY, CIP, VAN | 1 |
| R6 | E, CIP, CAF, AMP, P, AMC | 1 |
| R7 | TE, E, CIP, CAF, AMP, P, AMC | 1 |
| R8 | TE, E, DOXY, CIP, CAF, AMP, P, AMC | 5 |
| R8 | TE, E, DOXY, CAF, AMP, P, AMC, VAN | 1 |
| R9 | TE, E, DOXY, CIP, CAF, AMP, P, AMC, VAN | 8 |
| Total | 18 |
Key; E erythromycin, TE tetracycline, AMP ampicillin, P penicillin, AMC amoxicillin/clavuanic acid, CAF chloramphenicol, CIP ciprofloxacin, DOXY doxycycline, VAN Vancomycin, R Resistance.R2-R9 Number of antibiotics resistance from 2 to 9, respectively. MDR organisms resistant to >2 antibiotics